Viral Control of Glioblastoma
Glioblastoma multiforme (GBM) is a universally lethal cancer of the central nervous system. Patients with GBM have a median survival of 14 months and a 5-year survival of less than 5%, a grim statistic that has remained unchanged over the last 50 years. GBM is intransigent for a variety of reasons....
Main Authors: | Nicole Mihelson, Dorian B. McGavern |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/13/7/1264 |
Similar Items
-
Oncolytic virotherapy using neural stem cells as a novel treatment option for glioblastoma multiforme
by: Tanvir Ahmed
Published: (2023-03-01) -
Advances in immunotherapy for glioblastoma multiforme
by: Ahmad Bakur Mahmoud, et al.
Published: (2022-10-01) -
Recent Advances on the Bovine Viral Diarrhea Virus Molecular Pathogenesis, Immune Response, and Vaccines Development
by: Anwar A. G. Al-Kubati, et al.
Published: (2021-05-01) -
Virus-Based Immunotherapy of Glioblastoma
by: Miika Martikainen, et al.
Published: (2019-02-01) -
Metástases intrarraquidianas de glioblastoma multiforme supratentorial da infância: relato de caso Spinal cord metastatic glioblastoma multiforme of childhood: case report
by: Patricia Imperatriz Porto Rondinelli, et al.
Published: (2002-09-01)